2,3-dihydroquinazolin compounds as NAV1.8 inhibitors

Abstract The present invention relates to Nav1.8 Inhibitor 2,3-dihydroquinazolin compounds of Formula (X); wherein Y', X', 1', R", R 2 , RT, R 5', R 6', R 7, and z' are as defined herein; or pharmaceutically acceptable salts or tautomer forms thereof, corresponding...

Full description

Saved in:
Bibliographic Details
Main Authors Jie GUANG, Mark ELBAN, Maben YING, William H. MILLER, Joseph J. ROMANO, David G. WASHBURN, Tram H. HOANG, Ming-Hsun HO, Roderick S. DAVIS, Mythily VIMAL
Format Patent
LanguageEnglish
Published 14.12.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Abstract The present invention relates to Nav1.8 Inhibitor 2,3-dihydroquinazolin compounds of Formula (X); wherein Y', X', 1', R", R 2 , RT, R 5', R 6', R 7, and z' are as defined herein; or pharmaceutically acceptable salts or tautomer forms thereof, corresponding pharmaceutical compositions or formulations, methods or processes of compound preparation, methods, compounds for use in, uses for and/or combination therapies for treating pain and/or pain-related or associated disease(s), disorder(s) or conditionss, respectively. R 3R X N(x) I5 (X
Bibliography:Application Number: AU20230270195